Evaxion Biotech As Stock Return On Equity
| EVAX Stock | USD 2.61 0.07 2.61% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Evaxion Biotech's long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year | ||
| Return On Equity | 6.40 | 6.72 |
Evaxion | Return On Equity | Build AI portfolio with Evaxion Stock |
Evaxion Biotech AS Company Return On Equity Analysis
Evaxion Biotech's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Evaxion Biotech Return On Equity | -2.06 |
Most of Evaxion Biotech's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evaxion Biotech AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Evaxion Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Evaxion Biotech is extremely important. It helps to project a fair market value of Evaxion Stock properly, considering its historical fundamentals such as Return On Equity. Since Evaxion Biotech's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Evaxion Biotech's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Evaxion Biotech's interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Evaxion Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Evaxion Biotech AS has a Return On Equity of -2.0644. This is 91.39% lower than that of the Biotechnology sector and 94.34% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Evaxion Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evaxion Biotech's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Evaxion Biotech could also be used in its relative valuation, which is a method of valuing Evaxion Biotech by comparing valuation metrics of similar companies.Evaxion Biotech is currently under evaluation in return on equity category among its peers.
Evaxion Biotech ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Evaxion Biotech's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Evaxion Biotech's managers, analysts, and investors.Environmental | Governance | Social |
Evaxion Fundamentals
| Return On Equity | -2.06 | ||||
| Return On Asset | -0.37 | ||||
| Operating Margin | (4.31) % | ||||
| Current Valuation | 21.98 M | ||||
| Shares Outstanding | 6.32 M | ||||
| Shares Owned By Insiders | 23.06 % | ||||
| Shares Owned By Institutions | 7.07 % | ||||
| Number Of Shares Shorted | 104.54 K | ||||
| Price To Book | 1.64 X | ||||
| Price To Sales | 5.14 X | ||||
| Revenue | 3.34 M | ||||
| Gross Profit | 3.29 M | ||||
| EBITDA | (9.77 M) | ||||
| Net Income | (10.55 M) | ||||
| Cash And Equivalents | 25.25 M | ||||
| Cash Per Share | 1.06 X | ||||
| Total Debt | 10.1 M | ||||
| Debt To Equity | 0.48 % | ||||
| Current Ratio | 6.47 X | ||||
| Book Value Per Share | 1.87 X | ||||
| Cash Flow From Operations | (12.94 M) | ||||
| Short Ratio | 1.01 X | ||||
| Earnings Per Share | (12.00) X | ||||
| Target Price | 13.25 | ||||
| Number Of Employees | 46 | ||||
| Beta | 0.12 | ||||
| Market Capitalization | 16.93 M | ||||
| Total Asset | 12.48 M | ||||
| Retained Earnings | (118.54 M) | ||||
| Working Capital | 4.4 M | ||||
| Net Asset | 12.48 M |
About Evaxion Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Evaxion Biotech AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evaxion Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evaxion Biotech AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Evaxion Stock Analysis
When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.